Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$1,962 Mln
P/E Ratio
39.93
P/B Ratio
4.62
Industry P/E
--
Debt to Equity
0.05
ROE
0.11 %
ROCE
10.72 %
Div. Yield
0 %
Book Value
4.44
EPS
0.57
CFO
$322.71 Mln
EBITDA
$155.93 Mln
Net Profit
$184.26 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Progyny (PGNY)
| 31.88 | 3.17 | 2.99 | -30.21 | -17.47 | 1.88 | -- |
|
BSE Sensex
| 1.23 | 1.57 | 3.97 | 7.26 | 11.47 | 20.39 | 11.18 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
|
|---|---|---|---|---|---|
|
Progyny (PGNY)
| -53.31 | 19.36 | -38.13 | 18.78 | 54.43 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 17.52 | 3,460.66 | -- | -99.72 | |
| 3.43 | 1,772.85 | -- | -13.71 | |
| 2.60 | 5.64 | -- | -- | |
| 418.64 | 386,162.33 | 17.52 | 15.88 |
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes... smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. Read more
Executive Chairman
Mr. David J. Schlanger
Executive Chairman
Mr. David J. Schlanger J.D.
Headquarters
New York, NY
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Progyny Inc (PGNY) stood at $ 607 Mln as on 31-Dec-24
The share price of Progyny Inc (PGNY) is $22.75 (NASDAQ) as of 25-Apr-2025 16:00 EDT. Progyny Inc (PGNY) has given a return of -17.47% in the last 3 years.
Progyny Inc (PGNY) has a market capitalisation of $ 1,962 Mln as on 25-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/E ratio of Progyny Inc (PGNY) is 39.93 times as on 25-Apr-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Progyny Inc (PGNY) and enter the required number of quantities and click on buy to purchase the shares of Progyny Inc (PGNY).
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
The CEO & director of Mr. David J. Schlanger. is Progyny Inc (PGNY), and CFO & Sr. VP is Mr. David J. Schlanger J.D..
There is no promoter pledging in Progyny Inc (PGNY).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
351
|
|
|
173
|
|
|
1
|
|
|
38,954
|
| Progyny Inc. (PGNY) | Ratios |
|---|---|
|
Return on equity(%)
|
11.14
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
4.66
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Progyny Inc (PGNY) was $0 Mln.
$-0.15
(
